← Back to Search

Compassion Intervention for Stress in LGBTQ+ Women

N/A
Recruiting
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be 18 years of age or older
Self-identify sexual identity as LGBQ+ or another non-heterosexual identity AND gender identity as cisgender woman, transgender, nonbinary, or other gender minority identity
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, follow-up (1-month)
Awards & highlights

Study Summary

This trial will test if self-compassion can help reduce stress among LGBTQ+ people.

Who is the study for?
This trial is for LGBQ+ individuals or those with other non-heterosexual identities who are cisgender women, transgender, nonbinary, or have another gender minority identity. Participants must be fluent in English, have internet access and an email address, be at least 18 years old, and live in Central NY.Check my eligibility
What is being tested?
The study is examining if a short self-compassion training can help reduce the physical and emotional stress responses in sexual minority women, transgender people, and nonbinary individuals when they're exposed to stress.See study design
What are the potential side effects?
Since this intervention involves psychological practice rather than medication or medical procedures, traditional side effects are not expected. However, participants may experience emotional discomfort during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I identify as LGBQ+ and as a cisgender woman, transgender, nonbinary, or another gender minority.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, follow-up (1-month)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, follow-up (1-month) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Blood Pressure
Change in Heart Rate
Change in Heart Rate Variability
+3 more
Secondary outcome measures
Change in Craving
Change in Dissociation
Change in PTSD Symptoms
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Compassion InterventionExperimental Treatment1 Intervention
Group II: No TrainingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Compassion Intervention
2014
N/A
~50

Find a Location

Who is running the clinical trial?

Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,504 Total Patients Enrolled
GLMA: Health Professionals Advancing LGBTQ+ EqualityUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities presently available to join this experiment?

"Indeed, the online records hosted on clinicaltrials.gov demonstrate that this medical study is actively seeking participants. It was initially posted on July 17th 2023 and has since been updated as of November 27th 2023. The trial needs 70 individuals from a single site to participate in order for it to be successful."

Answered by AI

How many people can partake in this clinical experiment?

"Yes, the information accessible from clinicaltrials.gov verifies that this study is actively seeking patients to enrol in the trial. It was initially posted on July 17th 2023 and most recently updated November 27th 2023; 70 participants are being sought at one site."

Answered by AI

What are the fundamental goals of this investigation?

"This medical trial aims to measure the Change in Salivary Cortisol across a Baseline, Immediate Follow-Up (40 minutes after Baseline), During TSST (45-50 minutes after Baseline), Immediate Post-TSST (20-30 minutes post-TSST onset) and Recovery Post-TSST (10-20 minutes after Immediate Post-TSST time point). Secondary objectives include evaluating Change in Craving with the 12 item Alcohol Craving Questionnaire - short form - revised, gauging changes in PTSD Symptoms using the PDS 5 questionnaire, and assessing shifts Substance Use with queries from 2020 National Survey"

Answered by AI
~17 spots leftby Aug 2024